Detalhe da pesquisa
1.
Randomised phase 2 study (JADE) of the HBV capsid assembly modulator JNJ-56136379 with or without a nucleos(t)ide analogue in patients with chronic hepatitis B infection.
Gut
; 72(7): 1385-1398, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36697207
2.
JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients With Chronic Infection.
Gastroenterology
; 159(2): 521-533.e9, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32343960
3.
Virology analysis of chronic hepatitis B virus-infected patients treated for 28 days with JNJ-56136379 monotherapy.
J Viral Hepat
; 27(11): 1127-1137, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32579776
4.
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infection.
Virol J
; 15(1): 26, 2018 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378602
5.
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.
BMC Infect Dis
; 17(1): 389, 2017 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577353
6.
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.
Transpl Infect Dis
; 19(3)2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28295849
7.
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.
J Hepatol
; 62(5): 1047-55, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596313
8.
Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 study.
Clin Infect Dis
; 59(11): 1579-87, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25192745
9.
The Tei index and asymptomatic myocarditis in children with severe dengue.
Pediatr Cardiol
; 34(6): 1307-13, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23397334
10.
Viral sequence analysis of chronic hepatitis B patients treated with the capsid assembly modulator JNJ-56136379 in the JADE phase 2a study.
Antiviral Res
; 216: 105660, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385475
11.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Lancet Gastroenterol Hepatol
; 8(9): 790-802, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37442152
12.
Ceftriaxone treatment failure in two cases of Enteric Fever caused by CTX-M15 positive Salmonella Typhi and its gastrointestinal carriage.
Indian J Med Microbiol
; 40(3): 459-461, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483998
13.
Bioinsecticidal activity of Murraya koenigii miraculin-like protein against Helicoverpa armigera and Spodoptera litura.
Arch Insect Biochem Physiol
; 78(3): 132-44, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21948662
14.
Predictors of acute kidney injury post-cardiopulmonary bypass in children.
Clin Exp Nephrol
; 15(4): 529-34, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21479987
15.
Nonclinical safety assessment of a synthetic peptide thrombopoietin agonist: effects on platelets, bone homeostasis, and immunogenicity and the implications for clinical safety monitoring of adverse bone effects.
Int J Toxicol
; 30(4): 385-404, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21832269
16.
Efficacy and safety of Guduchighana Vati in asymptomatic and mild-to-moderate cases of coronavirus disease-19: A randomized controlled pilot study.
Ayu
; 41(3): 188-196, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-35370379
17.
A retrospective analysis of the effect of the intervention of Arogya Kashayam in COVID-19 positive cases in Madhya Pradesh.
Ayu
; 40(4): 209-215, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-33935437
18.
Pharmacokinetics of otamixaban, a direct factor Xa inhibitor, in healthy male subjects: pharmacokinetic model development for phase 2/3 simulation of exposure.
J Clin Pharmacol
; 46(1): 37-44, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16397282
19.
Pharmacokinetic/pharmacodynamic relationships for otamixaban, a direct factor Xa inhibitor, in healthy subjects.
J Clin Pharmacol
; 46(1): 45-51, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16397283
20.
Hypertriglyceridemia Thalassemia Syndrome: Common Disease, Uncommon Association.
Indian J Pediatr
; 83(7): 720-2, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26935201